| Literature DB >> 33852895 |
Alex Penev1, Andrew Bazley2, Michael Shen2, Jef D Boeke3, Sharon A Savage4, Agnel Sfeir5.
Abstract
Telomere length control is critical for cellular lifespan and tumor suppression. Telomerase is transiently activated in the inner cell mass of the developing blastocyst to reset telomere reserves. Its silencing upon differentiation leads to gradual telomere shortening in somatic cells. Here, we report that transcriptional regulation through cis-regulatory elements only partially accounts for telomerase activation in pluripotent cells. Instead, developmental control of telomerase is primarily driven by an alternative splicing event, centered around hTERT exon 2. Skipping of exon 2 triggers hTERT mRNA decay in differentiated cells, and conversely, its retention promotes telomerase accumulation in pluripotent cells. We identify SON as a regulator of exon 2 alternative splicing and report a patient carrying a SON mutation and suffering from insufficient telomerase and short telomeres. In summary, our study highlights a critical role for hTERT alternative splicing in the developmental regulation of telomerase and implicates defective splicing in telomere biology disorders. Published by Elsevier Inc.Entities:
Keywords: SON; alternative splicing; hTERT; pluripotent cells; telomerase; telomeres
Mesh:
Substances:
Year: 2021 PMID: 33852895 PMCID: PMC8943697 DOI: 10.1016/j.molcel.2021.03.033
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328